22 May 2013
Keywords: genelabs, files, ind, technologies, inc, filed, investigational
Article | 25 January 1993
- Genelabs Technologies Inc has filed an Investigational New Drug
application in the USA for its GL331, a chemotherapy-resistant tumor
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
21 May 2013
© 2013 thepharmaletter.com